Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Olfaction Disorders × Dronabinol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 4 Pain 4 Neoplasms 4 Nausea 3 Pancreatic Neoplasms 2 Cancer Pain 2 Breast Neoplasms 2 Taste Disorders 1 Parasomnias 1 Olfaction Disorders 1 Marijuana Abuse 1 Malnutrition 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Anxiety Disorders 1 Anorexia 1

Interventions

Dronabinol 1 Docosahexaenoic Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00316563 2010-02-09

Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study

AHS Cancer Control Alberta

Phase 2 Completed

Anorexia, Olfaction Disorders, Neoplasms, Taste Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡